Email Alert RSS
Volume 12 Issue 3
May  2021
Turn off MathJax
Article Contents
Abstract
References
Related Articles
XIAO Jiawang, ZHU Xianyang. Evolution of Interventional Treatment of Congenital Heart Disease in China[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(3): 303-308. DOI: 10.12290/xhyxzz.2021-0157
Citation: XIAO Jiawang, ZHU Xianyang. Evolution of Interventional Treatment of Congenital Heart Disease in China[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(3): 303-308. DOI: 10.12290/xhyxzz.2021-0157
shu

Evolution of Interventional Treatment of Congenital Heart Disease in China

  • Department of Congenital Heart Disease, General Hospital of Northern Theater Command, Shenyang 110016, China

More Information
  • Corresponding author:

    ZHU Xianyang  Tel: 86-24-28897421, E-mail: xyangz2011@163.com

  • Received Date: February 03, 2021
  • Accepted Date: March 22, 2021
  • Issue Publish Date: May 29, 2021
    Graphical Abstract
    • Abstract
  • Congenital heart disease(CHD) are the most common congenital malformations in China. It has been more than 50 years since the development from the traditional thoracotomy to percutaneous intervention. The interventional treatment of CHD has changed from the palliative procedure of atrial septostomy with balloon catheter to a radical cure for closure defects and stenosis of vessels or valves with balloon dilation and stent implantation. The treatment model has developed from a single specialty to multidisciplinary procedures comprised of internal and surgical medicine. With the clinical application of self-developed home-made equipment with Chinese characteristics and the accumulation of experience in innovating and perfecting skillful operation techniques, a series of remarkable achievements have been made in interventional therapy of CHD in China, which has brought the types and the number of congenital heart diseases treated with interventional treatment to the world-leading level. This article summarizes the development and achievements of interventional therapy of CHD in China and looks forward to the future trend in this field, so that clinicians can have a thought and lesson.
    • FullText(HTML)
    • References (49)
  • [1]
    中华人民共和国卫生部. 中国出生缺陷报告(2012)[EB/OL ]. [2012-09-12]. http://www.gov.cn/gzdt/2012-09/12/content_2223371.htm.
    [2]
    Rashkind WJ, Miller WW. Transposition of the great arteries: Results of palliation by balloon atrioseptostomy in thirty-one infants[J]. Circulation, 1968, 38: 453-462. DOI: 10.1161/01.CIR.38.3.453
    [3]
    Porstmann W, Wierny L, Warnke H. Closure of persistent ductus arteriosus without thoracotomy[J]. Ger Med Mon, 1967, 12: 259-261. http://eurheartjsupp.oxfordjournals.org/lookup/external-ref?access_num=6045537&link_type=MED&atom=%2Fehjsupp%2F12%2Fsuppl_E%2FE2.atom
    [4]
    戴汝平. 开拓介入治疗新领域-先天性心脏病的介入治疗[J]. 中华心血管病杂志, 2000, 28: 85-86. DOI: 10.3760/j:issn:0253-3758.2000.02.001
    [5]
    周爱卿, 王荣发, 高伟, 等. 复杂性先天性心脏病的介入治疗[J]. 中华儿科杂志, 2004, 42: 813-816. DOI: 10.3760/j.issn:0578-1310.2004.11.004
    [6]
    陈传荣, 李海, 周颖珍, 等. 经皮穿刺气囊肺动脉瓣成形术[J]. 中华心血管病杂志, 1986, 14: 132. https://www.cnki.com.cn/Article/CJFDTOTAL-JZYX504.014.htm
    [7]
    Gao W, Zhou AQ, Wang RH, et al. Percutaneous balloon aortic valvuloplasty in the treatment of congenital valvular aortic stenosis in children[J]. Chine Med J, 2001, 114: 453-455. http://www.ncbi.nlm.nih.gov/pubmed/11780401/
    [8]
    钱晋卿, 谢亚藩, 沈维英, 等. 非开胸法关闭动脉导管130例报告[J]. 中华心血管病杂志, 1992, 20: 167-168. DOI: 10.3760/j:issn:0253-3758.1992.03.001
    [9]
    蒋世良. 先天性心脏病介入治疗的现状和展望[J]. 中华心血管病杂志, 2009, 37: 970-971. DOI: 10.3760/cma.j.issn.0253-3758.2009.11.004
    [10]
    蒋世良, 黄连军, 徐仲英, 等. 先天性心脏病介入治疗的严重并发症分析及其防治[J]. 中国循环杂志, 2005, 20: 23-26. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGXH200501010.htm
    [11]
    朱鲜阳, 韩秀敏, 全薇, 等. 肌部室间隔缺损封堵治疗成功2例报告[J]. 沈阳部队医药, 2002, 15: 229-230.
    [12]
    Gu X, Han YM, Titus JL, et al. Transcatheter closure of membranous ventricular septal defects with a new nitinol prosthesis in a natural swine model[J]. Catheter Cardiovasc Interv, 2000, 50: 502-509. DOI: 10.1002/1522-726X(200008)50:4<502::AID-CCD29>3.0.CO;2-8
    [13]
    Pinto RJ, Dalvi BV, Sharma S. Transcatheter closure of perimembranous ventricular septal defects using amplatzer asymmetric ventricular septal defect occluder: preliminary experience with 18-month follow up[J]. Catheter Cardiovasc Interv, 2006, 68: 145-152. DOI: 10.1002/ccd.20813
    [14]
    Marinakis A, Vydt T, Dens J, et al. Percutaneous transcatheter ventricular septal defect closure in adults with Amplatzer septal occluders[J]. Acta Cardiol, 2007, 62: 391-395. DOI: 10.2143/AC.62.4.2022283
    [15]
    秦永文, 赵仙先, 李卫萍, 等. 应用自制封堵器经导管闭合膜部室间隔缺损[J]. 介入放射学杂志, 2002, 11: 130-131. DOI: 10.3969/j.issn.1008-794X.2002.02.021
    [16]
    Qin YW, Chen JM, Zhao XX, et al. Transcatheter closure of perimembranous ventricular septal defect using a modified double-disk occluder[J]. Am J Cardiol, 2008, 101: 1781-1786. DOI: 10.1016/j.amjcard.2008.02.069
    [17]
    中国医师协会心血管内科医师分会先天性心脏病工作委员会. 常见先天性心脏病介入治疗中国专家共识二、室间隔缺损介入治疗[J]. 介入放射学杂志, 2011, 20: 87-92. DOI: 10.3969/j.issn.1008-794X.2011.02.002
    [18]
    张玉顺, 张军, 吴栋良, 等. 房间隔缺损介入治疗中超声测量房缺最大径与球囊伸展径的相关研究[J]. 心脏杂志, 2002, (2): 154-156. DOI: 10.3969/j.issn.1009-7236.2002.02.022
    [19]
    谭洪文, 张志钢, 陈翔, 等. 室间隔缺损封堵术中改良保留导丝技术的临床应用[J]. 介入放射学杂志, 2014, 23: 753-756. DOI: 10.3969/j.issn.1008-794X.2014.09.04
    [20]
    曾筝, 戴汝平, 蒋世良, 等. 先天性心脏病冠状动脉瘘的介入治疗[J]. 中华放射学杂志, 1997, 6: 392-395. DOI: 10.3760/j.issn:1005-1201.1997.06.009
    [21]
    朱鲜阳. 经导管介入治疗主-肺动脉间隔缺损一例[J]. 中华儿科杂志, 2004, 42: 551. DOI: 10.3760/j.issn:0578-1310.2004.07.027
    [22]
    于波, 侯静波, 陈延军, 等. 主动脉窦瘤破裂介入封堵成功一例(个案)[J]. 中国循环杂志, 2004, 19: 186-187. https://www.cnki.net/KCMS/detail/detail.aspx?dbcode=IPFD&filename=ZHYX200403001203&dbname=IPFD9914
    [23]
    朱鲜阳, 韩秀敏, 崔春生, 等. 经导管射频打孔并球囊扩张治疗婴儿室间隔完整的肺动脉瓣闭锁[J]. 中华儿科杂志, 2007, 45: 194-198. DOI: 10.3760/j.issn:0578-1310.2007.03.009
    [24]
    Liu S, Xu X, Chen F, et al. Angiographic features of ruptured sinus of Valsalva aneurysm: new classification[J]. J Cardiol, 2014, 64: 139-144. DOI: 10.1016/j.jjcc.2013.12.004
    [25]
    Liu S, Xu X, Zhao X, et al. Percutaneous closure of ruptured sinus of Valsalva aneurysm: results from a multicentre experience[J]. Euro Interv, 2014, 10: 505-512. http://www.ncbi.nlm.nih.gov/pubmed/25138188
    [26]
    张刚成. 新时代背景下先天性心脏病的镶嵌治疗[J]. 中国实用内科杂志, 2019, 39: 583-586. https://www.cnki.com.cn/Article/CJFDTOTAL-SYNK201907004.htm
    [27]
    肖家旺, 王琦光, 张端珍, 等. 先天性心脏病术后房、室间隔残余分流的介入治疗[J]. 中国介入心脏病学杂志, 2020, 28: 500-504. DOI: 10.3969/j.issn.1004-8812.2020.09.005
    [28]
    李俊杰, 张智伟, 钱明阳, 等. 经导管弹簧圈堵闭小儿动脉导管未闭结扎术后残余分流[J]. 岭南心血管病杂志, 2001, 4: 237-238. DOI: 10.3969/j.issn.1007-9688.2001.04.003
    [29]
    Zhu XY, Qin YW, Han YL, et al. Long-term efficacy of transcatheter closure of ventricular septal defect in combina-tion with percutaneous coronary intervention in patients with ventricular septal defect complicating acute myocardial infarction: A multicenter study[J]. Euro Intervention, 2013, 8: 1270-1276. http://europepmc.org/abstract/med/23538156
    [30]
    周爱卿, 蒋世良. 先天性心脏病经导管介入治疗指南[J]. 中华儿科杂志, 2004, 55: 76-81. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHEK200403035.htm
    [31]
    中国医师协会心血管内科医师分会先天性心脏病工作委员会. 常见先天性心脏病介入治疗中国专家共识一、房间隔缺损介入治疗[J]. 介入放射学杂志, 2011, 20: 3-9. DOI: 10.3969/j.issn.1008-794X.2011.01.002
    [32]
    中国医师协会心血管内科医师分会先天性心脏病工作委员会. 常见先天性心脏病介入治疗中国专家共识三、动脉导管未闭的介入治疗[J]. 介入放射学杂志, 2011, 20: 172-176. DOI: 10.3969/j.issn.1008-794X.2011.03.002
    [33]
    中国医师协会心血管内科医师分会先天性心脏病工作委员会. 常见先天性心脏病介入治疗中国专家共识四、经皮球囊肺动脉瓣与主动脉瓣成形术[J]. 介入放射学杂志, 2011, 20: 253-260. DOI: 10.3969/j.issn.1008-794X.2011.04.001
    [34]
    中国医师协会儿科医师分会先天性心脏病专家委员会, 中华医学会儿科学分会心血管学组, 《中华儿科杂志》编辑委员会. 儿童常见先天性心脏病介入治疗专家共识[J]. 中华儿科杂志, 2015, 53: 17-24. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGYI201505007.htm
    [35]
    中华医学会心血管病学分会结构性心脏病学组, 中国医师协会心血管内科医师分会结构性心脏病专业委员会. 中国动脉导管未闭介入治疗指南2017[J]. 中国介入心脏病学杂志, 2017, 25: 241-248. https://www.cnki.com.cn/Article/CJFDTOTAL-ZJXB201705001.htm
    [36]
    张玉顺, 蒋世良, 朱鲜阳, 等. 卵圆孔未闭相关卒中预防中国专家指南[J]. 心脏杂志, 2021, 33: 1-10.
    [37]
    Baumgartner H, De Backer J, Babu-Narayan SV, et al. 2020 ESC Guidelines for the management of adult congenital heart disease[J]. Eur Heart J, 2021, 42: 563-645. http://www.researchgate.net/publication/344009503_2020_ESC_Guidelines_for_the_management_of_adult_congenital_heart_disease/download
    [38]
    中华人民共和国卫生部医政司. 心血管疾病介入诊疗技术管理规范(2011年版)[J]. 中国医学前沿杂志(电子版), 2012, 4: 76-78. https://www.cnki.com.cn/Article/CJFDTOTAL-YXQY201202032.htm
    [39]
    谢育梅, 邱庆欢, 张智伟, 等. 生物陶瓷镀膜封堵器治疗儿童左向右分流型先天性心脏病的中远期随访研究[J]. 中华实用儿科临床杂志, 2015, 30: 818-822.
    [40]
    潘湘斌, 逄坤静, 欧阳文斌, 等. 单纯超声心动图引导下经皮室间隔缺损封堵术的应用研究[J]. 中国循环杂志, 2015, 30: 774-776. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGXH201508017.htm
    [41]
    潘湘斌, 胡盛寿, 欧阳文斌, 等. 单纯超声引导下经皮肺动脉瓣球囊成形术的应用研究[J]. 中华小儿外科杂志, 2015, 36: 286-288.
    [42]
    潘湘斌, 欧阳文斌, 李守军, 等. 单纯超声心动图引导下行动脉导管未闭封堵术的安全性和有效性[J]. 中华心血管病杂志, 2015, 43: 31-33.
    [43]
    杨帆, 郑宏, 吕建华, 等. 3D打印技术指导下采用动脉导管未闭封堵器治疗下腔型房间隔缺损一例[J]. 中华心血管病杂志, 2015, 43: 631-633.
    [44]
    周达新, 潘文志, 管丽华, 等. 经皮肺动脉瓣置入二例报道[J]. 中国介入心脏病学杂志, 2013, 21: 332-334. https://www.cnki.com.cn/Article/CJFDTOTAL-ZJXB201305025.htm
    [45]
    中华医学会心血管病学分会结构性心脏病学组, 中国医师协会心血管内科医师分会结构性心脏病专业委员会. 经皮肺动脉瓣置入术中国专家建议[J]. 中国医学前沿杂志(电子版), 2016, 8: 20-24. https://www.cnki.com.cn/Article/CJFDTOTAL-ZJXB201610001.htm
    [46]
    谢育梅, 陈军. 可降解封堵器治疗先天性心脏病的研究进展[J]. 中华实用儿科临床杂志, 2020, 35: 2-6.
    [47]
    泮思林. 我国胎儿先天性心脏病介入治疗的探索和展望[J]. 介入放射学杂志, 2019, 28: 917-922. https://www.cnki.com.cn/Article/CJFDTOTAL-JRFS201910001.htm
    [48]
    罗刚, 刘娜, 刘爱, 等. 胎儿介入治疗肺动脉瓣闭锁伴室间隔完整(附10例报告)[J]. 中国实用儿科杂志, 2020, 35: 132-136. https://www.cnki.com.cn/Article/CJFDTOTAL-ZSEK202002013.htm
    [49]
    Xing QS, Wu Q, Shi L, et al. Minimally invasive transthoracic device closure of isolated ventricular septal defect without cardiopulmonary bypass: long-term follow-up results[J]. J Thorac Cardiovasc Surg, 2015, 149: 257-264. http://smartsearch.nstl.gov.cn/paper_detail.html?id=2be3012e358e3f69ca221905cfc9f0f5
    • Related Articles

  • Related Articles

    [1]TIAN Kunling, CHEN Chuanning. Notch Signaling Pathway and Congenital Heart Disease[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(3): 649-654. DOI: 10.12290/xhyxzz.2023-0594
    [2]LI Wei, XU Lingling, HU Yingli, ZHU Huijuan, LI Yuxiu, XIA Weibo. Integrating Education of School History into Teaching of Clinical Courses and Developing Professional Courses with PUMC Characteristics: Taking Diabetes Teaching in Internal Medicine as an Example[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(5): 1111-1115. DOI: 10.12290/xhyxzz.2023-0148
    [3]ZHANG Lu, LI Jian. Castleman Disease in China: State-of-the-art Technology Before the Era of IL-6 Targeted Therapy[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(5): 911-914. DOI: 10.12290/xhyxzz.2023-0227
    [4]Rare Diseases Society of Chinese Research Hospital Association, National Rare Diseases Committee, Beijing Rare Disease Diagnosis, Treatment and Protection Society, Gitelman Syndrome Consensus Working Group. Expert Consensus for the Diagnosis and Treatment of Gitelman Syndrome in China (2021)[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(6): 902-912. DOI: 10.12290/xhyxzz.2021-0555
    [5]LIU Xinpei, MIAO Qi, LIU Jianzhou. Potts Shunt for Refractory Pulmonary Hypertension: Historical and Future Perspectives[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(3): 313-317. DOI: 10.12290/xhyxzz.2021-0047
    [6]QIN Yongwen, BAI Yuan. History and Development of Interventional Devices forCongenital Heart Diseases in China[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(3): 309-312. DOI: 10.12290/xhyxzz.2021-0148
    [7]ZHANG Hao, LI Shoujun, SU Zhanhao. Reflections on Improving the Diagnosis and Treatment of Congenital Heart Diseasein China: the Regionalization of Care for Congenital Heart Surgery[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(3): 287-290. DOI: 10.12290/xhyxzz.20200280
    [8]Zhi-tong GE, Jian-chu LI. Application of Ultrasonic Intervention in the Treatment of Vascular Diseases[J]. Medical Journal of Peking Union Medical College Hospital, 2020, 11(1): 62-67. DOI: 10.3969/j.issn.1674-9081.20190210
    [9]Cardiovascular Intervention: A Companion to Braunwald's Heart Disease(2016)[J]. Medical Journal of Peking Union Medical College Hospital, 2016, 7(1): 65-65.
    [10]Ming-sheng MA, Xü-de ZHANG, Min WEI, Shi-min ZHAO, Zheng-qing QIU. Efficacy of Low Dose Corticosteroid Therapy in Duchenne Muscular Dystrophy[J]. Medical Journal of Peking Union Medical College Hospital, 2014, 5(4): 384-388. DOI: 10.3969/j.issn.1674-9081.2014.04.006

  • Cited by

    Periodical cited type(10)

    1. 王文鑫，董鑫，张鑫，许建国，何小龙，刘成飞，移康，尤涛. 单纯超声心动图引导与放射线引导经皮封堵房间隔缺损疗效比较的系统评价与Meta分析. 中国胸心血管外科临床杂志. 2023(10): 1490-1498 .
    2. 李怡坚，赵振刚，冯沅，陈茂. 结构性心脏病介入治疗的主要发展历程及进展. 中华心血管病杂志. 2023(10): 1022-1027 .
    3. 袁昕，郑杨. 依托咪酯在小儿先天性心脏病介入治疗中的应用效果. 妇儿健康导刊. 2023(12): 89-91 .
    4. 朱鲜阳. 先天性心脏病介入治疗现状及进展. 临床军医杂志. 2022(04): 331-333+338 .
    5. 杨启才，任凌，徐闵，李正义. 先天性心脏病介入治疗术后血清钾、钠、氯水平变化及临床意义. 中国医药科学. 2022(09): 188-191 .
    6. 刘晋萍. 浅谈新时代先天性心脏病外科格局变化下的儿科体外循环应对与挑战. 中国体外循环杂志. 2022(04): 193-195 .
    7. 徐亮，杨旭. 先天性心脏病介入手术围术期应注意的问题. 中国临床医生杂志. 2022(09): 1020-1022 .
    8. 李子林，张静隆，梁宏亮，陈佳，李超，左健. 临床路径指导先天性心脏病室间隔缺损介入治疗应用研究. 空军军医大学学报. 2022(09): 1010-1012+1017 .
    9. 曹景颖，吴信，陈寄梅，张海波，王辉山，董念国，严勤，李守军，庄建，屈正. 坚守初心与使命——我国先天性心脏病事业的开创与继承. 中国心血管病研究. 2021(07): 577-581 .
    10. 夏斌，孙忠东. 永远跳动的“心”, 心脏外科的发展和进步. 医学综述. 2021(18): 3537-3540+3545 .

    Other cited types(8)

Catalog

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (1129) PDF downloads (203) Cited by(18)
    Related
    Links: National Health Commission of the People's Republic of China Chinese Academy of Medical Sciences(CAMS) AMLC Check CNKI Database CNKI Term Online Chinese General Practice
    Address：Room 302,Third Floor,Building 7, No. 1 Shuaifuyuan, Wangfujing, Dongcheng District, Beijing 100730, China
    Tel：010-69154261/4262
    E - mail：medj@pumch.cn mjpumch@126.com
    Copyright of website：Editorial Office of Medical Journal of Peking Union Medical College Hospital

    Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return
    x Close Forever Close